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METHODS:
We employed a decision tree model to evaluate the cost-utility, from the perspective of a hospital/ insurer, of immediate reconstruction with bilateral paraspinous muscle flaps relative to primary incision closure after oncologic spine surgery. A systematic review of the literature on oncologic spine surgery and immediate and delayed spinal wound reconstruction was performed to estimate health state probabilities. Costs were estimated using 2014 Center for Medicare and Medicaid Services data for relevant associated CPT and DRG codes. Overall expected cost and quality-adjusted life years (QALYs) were assessed using a Monte Carlo simulation and sensitivity analyses.
RESULTS:
Bilateral paraspinous muscle flaps performed in conjunction with oncologic spine surgery had an expected cost of $81,458.90 and an expected average QALY of 24.19, whereas primary wound closure (no reconstruction) had an expected cost of $83,434.34 and an expected average QALY of 24.17, making immediate soft tissue reconstruction the dominant, most cost-effective strategy. Monte Carlo sensitivity analysis demonstrated that immediate soft tissue reconstruction was the preferred and most cost-effective option in a statistically significantly greater number of iterations (81.3 percent vs. 18.7%; p<0.001), supporting its overall greater cost-utility. Even when the willingness-to-pay threshold varied from $0 to $100,000 per QALY, immediate soft tissue reconstruction remained the dominant strategy across all iterations.
CONCLUSION:
This cost-utility analysis suggests that performing bilateral paraspinous muscle flaps in conjunction with oncologic spine surgery is more cost-effective than primary spine incision closure alone. 
PURPOSE:
The AeroForm tissue expander is a carbon dioxide-filled breast tissue expander that allows gradual, needle-free expansion using a hand-held remote controller. This study evaluates two-stage, prepectoral tissue expander-to-implant breast reconstruction with the carbondioxide tissue expanders and compares the outcomes to our recent experience with saline tissue expanders.
METHODS:
This was a retrospective study of consecutive patients from a single institution. The subjects consisted of women who underwent mastectomy and either immediate or delayed breast reconstruction with AeroForm or saline tissue expanders. Outcomes encompassed postoperative complications including mastectomy flap necrosis, infection requiring readmission and/or intravenous antibiotics, capsular contracture, hematoma, seroma, skin dehiscence, extrusion, premature explant, and loss of communication with the device (AeroForm) or rupture of the device (saline).
